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In recent times, the number of patients receiving antiplatelet drugs for the prevention of cardiovascular
and cerebrovascular diseases has been increasing. We examined the possibility of early initiation of
antiplatelet therapy after urological operations. Between April 2008 and February 2009, 62 patients who
received antiplatelet drugs and underwent urological surgeries (open surgery, transurethral surgery and
laparoscopic surgery) and prostate biopsies were examined. Of the 62 patients, 59 were randomized into 2
groups ; 32 patients receiving antiplatelet treatment initiation within 24 hours (early group) and 29 patients
receiving this treatment more than 24 hours (late group) after the urological operation. The end point of this
study was the re-cessation of antiplatelet therapy because of the development of postoperative complications
(hematuria, blood loss, etc.) and cardiovascular and cerebrovascular events within 1 month. There was no
significant difference in the urological events observed between these groups, including 2 of the 32 (6.3%)
patients in the early group and 3 of the 27 (11.1%) in the late group. Cardiovascular and cerebrovascular
diseases were not noted in any of the patients within 1 month. In conclusion, we think that it is possible to
initiate antiplatelet therapy within 24 hours after urological operations and prostate biopsies in the absence of
active blood loss. Early initiation may prevent the risk of cardiovascular and cerebrovascular disease in the
future.
(Hinyokika Kiyo 56 : 351-354, 2010)


















対 象 と 方 法
1）対 象


































































early 群）で 2例（膀胱タンポナーデ 1例，創部裂開
1例），後期再開群（以下 late 群）で 3例（膀胱タン




Table 1. Characteristics of urological operations
and groups
Operation ○1 Early 群 ○2 Late 群 Total
腎，前立腺手術 6例 6例 12例
前立腺生検 11例 6例 17例
TURP 4例 3例 7例
TURBT 8例 7例 15例
その他 3例 5例 8例
Total 32例 27例 59例
Mann-Whitney’s U test. p＝0.726.
Table 2. Results of postoperative complications
about all operations
Postoperative complications (all operations)
あ り な し Total
Early 群 2例 30例 32例
Late 群 3例 24例 27例
Fisher’s exact test. p＝0.420.
Table 3. Results of postoperative complications
except biopsies
Postoperative complications (except biopsies)
あ り な し Total
Early 群 2例 19例 21例
Late 群 3例 18例 21例
Fisher’s exact test. p＝0.50.
Table 4. Results of postoperative complications
about TUR
Postoperative complications (about TUR)
あ り な し Total
Early 群 1例 11例 12例
Late 群 1例 10例 11例
Fisher’s exact test. p＝0.739.
術後 1カ月以内赤血球尿沈渣 (about TUR)
20未満/hpf 20以上/hpf および炎症例 Total
Early 群 4例 8例 12例
Late 群 3例 8例 11例
Fisher’s exact test. p＝0.556.





























1996年の American College of Cardiology (ACC)/AHA
Guidelines on Perioperative Cardiovascular evaluation for






































activated partial thromboplastin time (APTT），dimmer，
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